Trial site
XCancer/Dothan Hematology & Oncology - 1114
- 1running trial
- 0closed trials
- 0trials confirmed by the site in the last 60 days
- –languages not stated
No trial has been confirmed here yet.
Running trials
Active, not recruiting
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
Researchers
No researcher is linked here yet.
Site data: ClinicalTrials.govUpdated 12 Nov 2026